Severity of non-immune hydrops fetalis at birth continues to predict survival despite advances in perinatal care

Fetal Diagn Ther. 2006;21(4):380-2. doi: 10.1159/000092469.

Abstract

Objectives: To describe the aetiology and short-term outcome of live-born infants with non-immune hydrops fetalis (NIH), to identify predictors of mortality and to establish whether there has been any change in mortality over a 14-year period.

Methods: A retrospective case note review of all liveborn neonates with NIH.

Results: 30 infants were identified. Twenty (66%) had an identifiable aetiology. Ten (33%) survived to discharge. Survivors had significantly higher Apgar scores at 1 and 5 min (both p<0.001). Mortality did not differ between the time periods 1990-1999 and 2000-2004.

Conclusions: NIH continues to be associated with a significant mortality despite advances in perinatal care. Poor condition at birth is a strong predictor of death.

MeSH terms

  • Female
  • Gestational Age
  • Humans
  • Hydrops Fetalis / etiology
  • Hydrops Fetalis / mortality*
  • Infant Mortality*
  • Infant, Newborn
  • Perinatal Care*
  • Pregnancy